OBI Pharma (4174) — Cash Flow Quality Index

Latest as of June 2023: -1.19x

OBI Pharma (4174) has a Cash Flow Quality Index of -1.19x as of June 2023. Operating cash flow of NT$-401.35 Million is below net income of NT$337.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore OBI Pharma cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.19x

Operating CF / Net Income

Operating Cash Flow

NT$-401.35 Million

TWD

Net Income

NT$337.00 Million

TWD

Data as of

Jun 2023

Most recent filing

Annual Cash Flow Quality Index for OBI Pharma (None–None)

Year-by-year earnings quality comparison for OBI Pharma.

Year	Quality Index	Operating CF (TWD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.